Wash U Spinout PerianDX Raises $30M

St. Louis’ Poop-Tech Startup

St. Louis Startup Scene: Big Sale, Distribution and $6M in VC

St. Louis Startup Scene: Funded, Partnered and Proof of Concept

Pluton Biosciences and Bayer AG to Investigate Microbial-Based Carbon Capture

PercayAI and Saint Louis University Partner to Accelerate AI Adoption in Biomedical Research

Canopy Biosciences Acquired by Bruker After 4 Years As BioGenerator Incubated Startup

Pluton Biosciences Joins Illumina Accelerator, a Genomics Corporate Innovation Program in San Diego

Gateway Biotechnology Raises $2.2M SBIR Grant from NIH

Adarza BioSystems Raises Another $25 Million to Launch Platform for Research and Drug Development

Geneoscopy Gets Key FDA Designation, Hires New Exec

Augmented Intelligence Company PercayAI Partners with Canopy Biosciences to Accelerate Drug Development

Kingdom Capital Collaborates with Washington University School of Medicine to Launch Augmented Intelligence Company PercayAI

The Bourbon Friday Show

The Bourbon Friday Show with Dr. Chris Ho from Drug Design Methodologies

The Bourbon Friday Show

The Bourbon Friday Show with Charlie Walch from Pluton Biosciences

Pluton Biosciences Successfully Raises $98,000 via Nvsted Regulation Crowdfunding Platform

Cortex Expands with Re-invention of Historic 4340 Duncan Building

VaxNewMo’s Vaccine Breakthrough Published in Nature

Crowdfunding Microbes that Eat Mosquito Larvae to Slow Spread of Disease is Latest Campaign on Nvsted

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

With Help From The Yield Lab, Aptimmune Biologics Gains Access to the Worldwide Market

St. Louis Has โ€œAgglomerationโ€ In AgTech, According To A Brookings Report, And Thatโ€™s A Good Thing

Arch Grants Global Startup Competition Entrants: Get Ready for Transformative Feedback

Bioscience Startup Founders: Expect Bumps in the Road From Academic to Entrepreneur


Local Immunotherapy Startup Attracts $3 Million Investment

St Louis Startup Boom Was 20 Years In The Making

Plastomics is Growing the Next Generation of Crops With Agtech

How Confluence Acquisition Will Work For Aclaris In St. Louis

St Louis Bioscience Startup Acquired at $100 Million Valuation

GlobalSTL Attracts International Healthcare Innovators by Focusing in on St. Louis Strengths

Cultivation Capital EQ Life Science

Trends in Life Science and Healthcare Innovation

The Agile Mission of BioGeneratorโ€™s Grants Program

Meet Bill Schmidt: Managing Partner at Cultivation Capital Life Sciences Fund

Ginger Imster

Ginger Imster on Making St. Louis a Startup Magnet

Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

Cortex-based Affigen Announces $17 million Series A Led by Black Beret Life Sciences

Automation team GlobalSTL

From Israel to Ireland: Checking in With GlobalSTL

As Adarza Scales Up, St. Louis Hopes for an Important Win

New Life Science Startup Raises $2 Million

Adarza BioSystems

Adarza BioSystems Closes on $17 Million – What’s Next for the Life Science Startup

Karen Gheesling Mullis

RiverVest Closes $15 Million Biopharma Pre-Seed Fund, Says It Will Focus on Midwest Companies

Applied Particle Technology

6 WashU faculty-founded startups show velocity for university business creation

GSK Partners With Startup to Develop Antibiotic Alternative


Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Founder Series: Joseph Monahan of Confluence

appistry managed services

Appistry Launches Managed Services for Clinical Laboratories

4 Key Findings from Express Scripts’ 2015 Drug Trend Report and What All Entrepreneurs Can Learn From Them

BioGenerator Lab

Breaking Down BioGenerator

How Arch Grantโ€™s Recipient Hemadvance Attracted its Startup Dream Team

Adarza BioSystems Raises $5 Million in Series B Investment Round

BioGenerator Company Accuronix Targets Pancreatic Cancer

Robert Beardsley on Galera Therapeutics’ High Growth

Jay Schmelter

Capital Ideas: Jay Schmelter of RiverVest

Cultivation Capital EQ Life Science

Life Sciences in St. Louis: Q/A with Rick Ryan, General Partner of Cultivation Capital

Thatโ€™s Life (Sciences)

Bio STL Global STL EQ

International Affair

Sam Altman of Y Combinator: โ€œWe Want To Hire More St. Louis Startups.โ€

Disrupting Infection with Nanotechnology and Tom Cohen

This Biomedical Startup is Taking on Life-Threatening Fibrotic Disease

Why (And How) You Should Use BioSTL’s Roadmap to Entrepreneurship

Whatโ€™s Next For St. Louis With Dr. Cheryl Watkins-Moore

John Talley Takes on Cancer with Euclises Pharmaceuticals

Cortex St. Louis

Cortex Announces Facilities Partnership with Wash U and SLU

Disrupting Genomics with Jarret Glasscock

Day 1 with Sq1: Lessons for First-Time Entrepreneurs

Why Evidence-Based Innovation is Great News for STL Biotech

STL-based Immunophotonics is Taking on Cancer Using Your Own Body

How St. Louis Startup Pulse Therapeutics Attracted Success

Can St. Louis Become the Next Bioscience Hub?

From NY To STL: Why This Life-Science Company Relocated To The Midwest